A Novel-Defined Necroptosis-Related miRNA Signature for Forecasting the Prognosis of Low-Grade Glioma

Table 5

Univariate logistic analysis of hsa-miR-200a-5p and clinical parameters.

Characteristics	Total ()	Odds ratio (OR)	value
WHO grade (G3 vs. G2)	467	1.192 (0.829-1.716)	0.344
1p/19q codeletion (noncodel vs. codel)	529	2.613 (1.796-3.831)	<0.001
Primary therapy outcome (PR&CR vs. PD&SD)	459	0.716 (0.494-1.036)	0.077
Age (>40 vs. ≤40)	529	1.690 (1.200-2.387)	0.003
IDH status (Mut vs. WT)	526	0.091 (0.045-0.168)	<0.001
Gender (male vs. female)	529	0.851 (0.604-1.199)	0.357